Table 3.
Disease Severity | ||||
---|---|---|---|---|
Characteristics | Nonsevere | Severe | Total | P Value |
No. (%) | 112 (78.87) | 30 (21.13) | 142 | |
CT score, median (IQR) | 0.00 (0.00–2.00) | 2.00 (2.00–2.00) | 0.00 (0.00–2.00) | <.001 |
CT changes, No. (%) | ||||
Normal | ||||
Yes | 17 (15.18) | 3 (10.00) | 21 (14.08) | .62 |
No | 95 (84.82) | 27 (90.00) | 122 (85.91) | |
Chronic and fibrotic changes | ||||
Yes | 41 (36.61) | 12 (40.00) | 52 (36.62) | .84 |
No | 71 (63.39) | 18 (60.00) | 90 (63.38) | |
Ground-glass opacity | ||||
Complete absorption | 70 (62.50) | 7 (23.33) | 77 (54.23) | .004 |
Partial absorption | 42 (37.50) | 22 (73.33) | 64 (45.07) | |
Increase | 0 (0.00) | 1 (3.34) | 1 (0.7) |
Abbreviations: COVID-19, coronavirus disease 2019; CT, computed tomography; GGO, ground-glass opacity; IQR, interquartile range.